Procept Biorobotics
PRCT
120 hedge funds and large institutions have $1.27B invested in Procept Biorobotics in 2023 Q2 according to their latest regulatory filings, with 26 funds opening new positions, 59 increasing their positions, 20 reducing their positions, and 22 closing their positions.
700% more call options, than puts
Call options by funds: $17.1M | Put options by funds: $2.14M
195% more repeat investments, than reductions
Existing positions increased: 59 | Existing positions reduced: 20
36% more capital invested
Capital invested by funds: $938M → $1.27B (+$333M)
20% more funds holding in top 10
Funds holding in top 10: 5 → 6 (+1)
18% more first-time investments, than exits
New positions opened: 26 | Existing positions closed: 22
6.42% more ownership
Funds ownership: 73.56% → 79.98% (+6.4%)
3% more funds holding
Funds holding: 116 → 120 (+4)
Top Buyers
Top Sellers
| 1 |
DCM
Driehaus Capital Management
Chicago,
Illinois
|
-$21.2M |
| 2 |
Citadel Advisors
Miami,
Florida
|
-$16.3M |
| 3 |
ECM
ExodusPoint Capital Management
New York
|
-$9.63M |
| 4 |
Voloridge Investment Management
Jupiter,
Florida
|
-$3.28M |
| 5 |
Lord, Abbett & Co
Jersey City,
New Jersey
|
-$3.07M |
PRCT Hedge Fund Activity: Q2 2023 in Review
120 of the 6,369 institutional investors tracked by Wall St. Rank reported a position in Procept Biorobotics (PRCT) for Q2 2023, worth a combined $1.27B — up 36% from $938M a quarter earlier.
Buyers outnumbered sellers: 26 funds opened new PRCT positions and 22 closed out — a net gain of 4 holders — while 59 added to existing stakes and 20 trimmed.
The largest buyer was BlackRock, adding an estimated $22.6M. The largest seller was Driehaus Capital Management, cutting an estimated $21.2M.
- 120 institutional investors held Procept Biorobotics (PRCT) as of Q2 2023, up from 116 in Q1 2023.
- Funds reported $1.27B of Procept Biorobotics stock for Q2 2023, up 36% quarter-over-quarter.
- 26 funds opened new Procept Biorobotics positions in Q2 2023 and 22 closed out, a net change of +4 holders.
- The largest Procept Biorobotics buyer in Q2 2023 was BlackRock, an estimated $22.6M added.
- The largest Procept Biorobotics seller in Q2 2023 was Driehaus Capital Management, an estimated $21.2M sold.
Based on aggregated 13F filings for Q2 2023.